Pfizer announces executive leadership team for Allergan merger
Pfizer has announced the executive leadership team for the combined Pfizer and Allergan business, which will be the world’s largest pharma company.
Archives for February 9, 2016
AstraZeneca: China formulated anaemia drug on fast-track, but timeframes vague
AstraZeneca has reformulated roxadustat using materials sourced in China to make it eligible for fast track review through the country's new "green pass" process.
Earthquake proof API plants a must in Taiwan according to Scinopharm
Most buildings in Taiwan are designed to withstand earthquakes according to Scinopharm, which told us such measures allowed its Tainan plant to survive a quake that felled a neighbouring tower block last week.
Janssen averse to extrapolation as FDA sits to review Remicade biosimilar
Celltrion’s CT-P13 has been declared “highly similar” in safety and efficacy to J&J’s Remicade, and could be recommended for approval by a US FDA committee today.
Sponsors: efficiency more important than CRO margins
A recent survey suggests that most sponsors are not concerned about CRO margins, which have reached an all-time high.
Lonza to make Kodiak Sciences' eye drug candidates
Lonza has been contracted to make candidate antibody-based drugs for retinal diseases by California, US biotech Kodiak Sciences.
UK Government selects Icon to manage genome project data
Genomics England has selected CRO Icon to manage data for what it says is the largest genome sequencing project of its kind for cancer and rare diseases.